Fig. 1From: Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the diseaseClinical monitoring of circulating DNA in NSCLC patients. a Clinical specimen characteristics and follow up measurement schedules. b Assay sensitivity to detect minute quantities of mutant copies via ddPCRBack to article page